Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application

• Hauptverfasser: Natasha Atanaskova Mesinkovska (Verfasst von), Danyelle Dawes (Verfasst von), Apra Sood (Verfasst von), Wilma Bergfeld (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2011-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%). Imiquimod has been associated with localized erythema, crusting, and scaling at the site of app...